{"resourceType":"Task","id":"mii-exa-molgen-medikationsempfehlung-fgfr2-fusion","meta":{"profile":["https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/medikationsempfehlung","http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/medication-recommendation"]},"basedOn":[{"reference":"ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"}],"status":"requested","intent":"proposal","code":{"coding":[{"system":"http://loinc.org","code":"LA26421-0","display":"Consider alternative medication"}],"text":"Hochselektive FGFR-Inhibitor-Therapie"},"for":{"reference":"Patient/mii-exa-molgen-patient-fgfr2-fusion"},"reasonReference":{"reference":"Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"}}